Non-valvular atrial fibrillation: impact of apixaban on patient outcomes
A Ioannou, I Tsappa, S Metaxa… - Patient Related …, 2017 - Taylor & Francis
Atrial fibrillation is the most common arrhythmia worldwide, and carries a significantly
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
Non-valvular atrial fbrillation: impact of apixaban on patient outcomes.
A Ioannou, I Tsappa, S Metaxa… - Patient Related Outcome …, 2020 - go.gale.com
Atrial fibrillation is the most common arrhythmia worldwide, and carries a significantly
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
[HTML][HTML] Non-valvular atrial fibrillation: impact of apixaban on patient outcomes
A Ioannou, I Tsappa, S Metaxa… - Patient Related …, 2017 - ncbi.nlm.nih.gov
Atrial fibrillation is the most common arrhythmia worldwide, and carries a significantly
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
Non-valvular atrial fibrillation: impact of apixaban on patient outcomes
A Ioannou, I Tsappa, S Metaxa… - Patient related …, 2017 - pubmed.ncbi.nlm.nih.gov
Atrial fibrillation is the most common arrhythmia worldwide, and carries a significantly
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
Non-valvular atrial fibrillation: impact of apixaban on patient outcomes
A Ioannou, I Tsappa, S Metaxa… - Patient Related Outcome …, 2017 - dovepress.com
Atrial fibrillation is the most common arrhythmia worldwide, and carries a significantly
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
[PDF][PDF] Non-valvular atrial fibrillation: impact of apixaban on patient outcomes
A Ioannou - 2017 - researchgate.net
Atrial fibrillation is the most common arrhythmia worldwide, and carries a significantly
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
Non-valvular atrial fibrillation: impact of apixaban on patient outcomes.
A Ioannou, I Tsappa, S Metaxa… - Patient Related Outcome …, 2017 - europepmc.org
Atrial fibrillation is the most common arrhythmia worldwide, and carries a significantly
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
[PDF][PDF] Non-valvular atrial fibrillation: impact of apixaban on patient outcomes
A Ioannou - 2017 - pdfs.semanticscholar.org
Atrial fibrillation is the most common arrhythmia worldwide, and carries a significantly
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
Non-valvular atrial fibrillation: impact of apixaban on patient outcomes
A Ioannou, I Tsappa, S Metaxa… - Patient Related …, 2017 - search.proquest.com
Atrial fibrillation is the most common arrhythmia worldwide, and carries a significantly
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
Non-valvular atrial fibrillation: impact of apixaban on patient outcomes
A Ioannou, I Tsappa, S Metaxa - Patient Related Outcome Measures, 2017 - go.gale.com
Atrial fibrillation is the most common arrhythmia worldwide, and carries a significantly
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …
increased risk of thromboembolic stroke. Initially, vitamin K antagonists were used as stroke …